Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE

Urology

Volumn 68, Issue 6, 2006, Pages 1242-1247

  Latini, David M ^a,b   Chan, June M ^c,d   Cowan, Janet E ^c   Arredondo, Shelley A ^c   Kane, Christopher J ^c,e   Penson, David F ^f   DuChane, Janeen ^g   Carroll, Peter R ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Program in Urologic Oncology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g TAP PHARMACEUTICAL PRODUCTS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INCOME; INSURANCE; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; URINARY TRACT;

AGED; BODY MASS INDEX; DIABETES MELLITUS; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; OBESITY; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 33845389629     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.08.1096     Document Type: Article

References (20)

1. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273 (1995) 129-135
2. Penson D.F., Latini D.M., Lubeck D.P., et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients?. Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 26 (2003) 1093-1099
3. Centers for Disease Control and Prevention. Diabetes: Disabling, Deadline, and on the Rise. (2006), Centers for Disease Control and Prevention, Atlanta, Coordinating Center for Health Promotion
4. Merrick G.S., Wallner K.E., and Butler W.M. Management of sexual dysfunction after prostate brachytherapy. Oncology 17 (2003) 52-62 (Huntingt) 67-70, 73
5. Herold D.M., Hanlon A.L., and Hanks G.E. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43 (1999) 475-479
6. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
7. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
8. Porter M.P., and Stanford J.L. Obesity and the risk of prostate cancer. Prostate 62 (2005) 316-321
9. Anast J.W., Sadetsky N., Pasta D.J., et al. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol 173 (2005) 1132-1138
10. Selek U., Cheung R., Lii M., et al. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 59 (2004) 1039-1046
11. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
12. Lubeck D.P., Litwin M.S., Henning J.M., et al., Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Research Panel: The CaPSURE database: a methodology for clinical practice and research in prostate cancer. Urology 48 (1996) 773-777
13. Cooperberg M.R., Broering J.M., Litwin M.S., et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol 171 (2004) 1393-1401
14. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002-1012
15. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
16. Cooperberg M.R., Pasta D.J., Elkin E.P., et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173 (2005) 1938-1942
17. Aiken L.S., and West S.G. Multiple Regression: Testing and Interpreting Interactions. (1991), SAGE Publications, Thousand Oaks, CA
18. Freedland S.J., Terris M.K., Presti Jr. J.C., et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 172 (2004) 520-524
19. Penson D.F., Latini D.M., Lubeck D.P., et al. Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes?. Results from the ExCEED data base. J Urol 169 (2003) 1458-1461
20. Arredondo S.A., Elkin E.P., Marr P.L., et al. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology 67 (2006) 559-565